University Grants Commission Tender
If you're a registered bidder for etender UP and want to inquire about any e-tender UP government has posted, this is your stop. No need to enter every detail on the website of <a href="https://etender.up.nic.in">etender.up.nic.in</a> - BidAssist filters will help you find the exact UP etender you're looking for. Read to learn how to search & bid for etender UP.
University Grants Commission - UGC Tender
Laboratory Equipment and Services
GEM
Opening Date25 Jul 2022
Closing Date16 Aug 2022
Tender Amount₹ 41,481 This is an estimated amount, exact amount may vary.
Costs
EMD
Refer DocumentsDocument Cost
Refer DocumentsTender Fee
Refer Documents
Description
Scription for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user
Contact
Tender Id
GEM/2022/B/2379726Bid Award Id
ViewTender No
GEM/2022/B/2379726Tender Authority
University Grants Commission ViewPurchaser Address
-Website
http://bidplus.gem.gov.in
GEM & Bid Advisory Services
Get portal registration, tender bidding, product/service listing or vendor/MSME certification services at a nominal cost
Documents
cci_bid_2022-07-25-14-47-01_149fb03203b5d5ecde09b52c8744df66.pdf
boq_ssh_cci_formated_2022-07-25-14-47-01_4e92fa8eb79d4802565e832d44038b26.csv
BOQ Items
TRIGLYCERIDES , Please refer Annexure II of Tender Document
1
-
-
HDL , Please refer Annexure II of Tender Document
1
-
-
LDL , Please refer Annexure II of Tender Document
1
-
-
UREA , Please refer Annexure II of Tender Document
1
-
-
CREATININE , Please refer Annexure II of Tender Document
1
-
-
SODIUM -Na , Please refer Annexure II of Tender Document
1
-
-
POTASSIUM -K , Please refer Annexure II of Tender Document
1
-
-
CHLORIDE -Cl , Please refer Annexure II of Tender Document
1
-
-
CALCIUM , Please refer Annexure II of Tender Document
1
-
-
PHOSPORUS , Please refer Annexure II of Tender Document
1
-
-
URIC ACID , Please refer Annexure II of Tender Document
1
-
-
TOTAL PROTEIN , Please refer Annexure II of Tender Document
1
-
-
ALBUMIN , Please refer Annexure II of Tender Document
1
-
-
SGOT , Please refer Annexure II of Tender Document
1
-
-
SGPT , Please refer Annexure II of Tender Document
1
-
-
ALP , Please refer Annexure II of Tender Document
1
-
-
BILIRUBIN TOTAL , Please refer Annexure II of Tender Document
1
-
-
BILIRUBIN DIRECT , Please refer Annexure II of Tender Document
1
-
-
Gamm GT , Please refer Annexure II of Tender Document
1
-
-
MAGNESIUM , Please refer Annexure II of Tender Document
1
-
-
AMYLASE , Please refer Annexure II of Tender Document
1
-
-
LIPASE , Please refer Annexure II of Tender Document
1
-
-
LDH , Please refer Annexure II of Tender Document
1
-
-
IRON , Please refer Annexure II of Tender Document
1
-
-
TIBC-UIBC , Please refer Annexure II of Tender Document
1
-
-
FERRITIN , Please refer Annexure II of Tender Document
1
-
-
CK , Please refer Annexure II of Tender Document
1
-
-
CK-MB , Please refer Annexure II of Tender Document
1
-
-
MICROALBUMIN , Please refer Annexure II of Tender Document
1
-
-
PROCALCITONINE , Please refer Annexure II of Tender Document
1
-
-
IMMUNOGLOBU LIN- G , Please refer Annexure II of Tender Document
1
-
-
IMMUNOGLOBU LIN- A , Please refer Annexure II of Tender Document
1
-
-
IMMUNOGLOBU LIN- M , Please refer Annexure II of Tender Document
1
-
-
CRP , Please refer Annexure II of Tender Document
1
-
-
ASO , Please refer Annexure II of Tender Document
1
-
-
RF , Please refer Annexure II of Tender Document
1
-
-
TRANSFERRIN , Please refer Annexure II of Tender Document
1
-
-
APO- A , Please refer Annexure II of Tender Document
1
-
-
APO- B , Please refer Annexure II of Tender Document
1
-
-
COMPLEMENT- C3 , Please refer Annexure II of Tender Document
1
-
-
COMPLEMENT- C4 , Please refer Annexure II of Tender Document
1
-
-
URINE PROTIEN , Please refer Annexure II of Tender Document
1
-
-
CSF PROTEIN , Please refer Annexure II of Tender Document
1
-
-
CSF GLUCOSE , Please refer Annexure II of Tender Document
1
-
-
FLUID PROTEIN , Please refer Annexure II of Tender Document
1
-
-
FLUID GLUCOSE , Please refer Annexure II of Tender Document
1
-
-
FLUID LDH , Please refer Annexure II of Tender Document
1
-
-
AMMONIA , Please refer Annexure II of Tender Document
1
-
-
CERULOPLASM1N , Please refer Annexure II of Tender Document
1
-
-
KAPPA , Please refer Annexure II of Tender Document
1
-
-
LAMDA , Please refer Annexure II of Tender Document
1
-
-
HOMOCYSTEINE , Please refer Annexure II of Tender Document
1
-
-
Vitmine- D , Please refer Annexure II of Tender Document
1
-
-
Cystatin- C , Please refer Annexure II of Tender Document
1
-
-
NGAL -Neutrophil Gelatinese Associated Lipocalin , Please refer Annexure II of Tender Document
1
-
-
CBC Plus Differential , Please refer Annexure II of Tender Document
1
-
-
Rectic , Please refer Annexure II of Tender Document
1
-
-
Platelet Count in Fluorescence - optical mode , Please refer Annexure II of Tender Document
1
-
-
PT , Please refer Annexure II of Tender Document
1
-
-
APTT , Please refer Annexure II of Tender Document
1
-
-
TT , Please refer Annexure II of Tender Document
1
-
-
AT III , Please refer Annexure II of Tender Document
1
-
-
Fibrinogen , Please refer Annexure II of Tender Document
1
-
-
Heparin , Please refer Annexure II of Tender Document
1
-
-
D-Dimer , Please refer Annexure II of Tender Document
1
-
-
Protein-C , Please refer Annexure II of Tender Document
1
-
-
Protein-S , Please refer Annexure II of Tender Document
1
-
-
F VIII , Please refer Annexure II of Tender Document
1
-
-
F IX , Please refer Annexure II of Tender Document
1
-
-
FDP , Please refer Annexure II of Tender Document
1
-
-
Fibrin Monomer , Please refer Annexure II of Tender Document
1
-
-
Free Phosphatidyl Serine , Please refer Annexure II of Tender Document
1
-
-
APCR- Activated Protein-C resistance , Please refer Annexure II of Tender Document
1
-
-
Vwf- Ag , Please refer Annexure II of Tender Document
1
-
-
Lupus Anticoagulant , Please refer Annexure II of Tender Document
1
-
-
vWF- RC o , Please refer Annexure II of Tender Document
1
-
-
AFP , Please refer Annexure II of Tender Document
1
-
-
CA 125 II , Please refer Annexure II of Tender Document
1
-
-
CA 15-3 , Please refer Annexure II of Tender Document
1
-
-
CA 19-9 -CA 19-9 XR , Please refer Annexure II of Tender Document
1
-
-
CEA , Please refer Annexure II of Tender Document
1
-
-
CYFRA 21-1 , Please refer Annexure II of Tender Document
1
-
-
HE-4 , Please refer Annexure II of Tender Document
1
-
-
Pepsinogen I , Please refer Annexure II of Tender Document
1
-
-
Pepsinogen II , Please refer Annexure II of Tender Document
1
-
-
PIVKA-II , Please refer Annexure II of Tender Document
1
-
-
ProGRP , Please refer Annexure II of Tender Document
1
-
-
PSA, Free , Please refer Annexure II of Tender Document
1
-
-
PSA, Total , Please refer Annexure II of Tender Document
1
-
-
ROMA HE4 and CA-125 , Please refer Annexure II of Tender Document
1
-
-
SCC , Please refer Annexure II of Tender Document
1
-
-
CA 72-4 , Please refer Annexure II of Tender Document
1
-
-
NSE , Please refer Annexure II of Tender Document
1
-
-
BNP , Please refer Annexure II of Tender Document
1
-
-
CK-MB , Please refer Annexure II of Tender Document
1
-
-
Galectin-3 , Please refer Annexure II of Tender Document
1
-
-
Homocysteine , Please refer Annexure II of Tender Document
1
-
-
Myoglobin , Please refer Annexure II of Tender Document
1
-
-
Troponin-I -high sensitive , Please refer Annexure II of Tender Document
1
-
-
NTproBNP , Please refer Annexure II of Tender Document
1
-
-
DHEA-S , Please refer Annexure II of Tender Document
1
-
-
Estradiol , Please refer Annexure II of Tender Document
1
-
-
FSH , Please refer Annexure II of Tender Document
1
-
-
hCG -total beta-hCG , Please refer Annexure II of Tender Document
1
-
-
LH , Please refer Annexure II of Tender Document
1
-
-
Progesterone , Please refer Annexure II of Tender Document
1
-
-
Prolactin , Please refer Annexure II of Tender Document
1
-
-
SHBG , Please refer Annexure II of Tender Document
1
-
-
Testosterone 2nd Generation , Please refer Annexure II of Tender Document
1
-
-
PCT -BRAHMS , Please refer Annexure II of Tender Document
1
-
-
Anti-HAV IgG , Please refer Annexure II of Tender Document
1
-
-
Anti-HAV IgM , Please refer Annexure II of Tender Document
1
-
-
Anti-HBc , Please refer Annexure II of Tender Document
1
-
-
Anti-HBc IgM , Please refer Annexure II of Tender Document
1
-
-
Anti-HBe , Please refer Annexure II of Tender Document
1
-
-
HBeAg Qualitative and Quantitative , Please refer Annexure II of Tender Document
1
-
-
Anti-HBs , Please refer Annexure II of Tender Document
1
-
-
HBsAg Qualitative , Please refer Annexure II of Tender Document
1
-
-
HBsAg Qualitative Confirmatory , Please refer Annexure II of Tender Document
1
-
-
HBsAg Quantitative , Please refer Annexure II of Tender Document
1
-
-
Anti-HCV , Please refer Annexure II of Tender Document
1
-
-
HCV Ag , Please refer Annexure II of Tender Document
1
-
-
HIV Ag-Ab Combo , Please refer Annexure II of Tender Document
1
-
-
CMV IgG , Please refer Annexure II of Tender Document
1
-
-
CMV IgG Avidity , Please refer Annexure II of Tender Document
1
-
-
CMV IgM , Please refer Annexure II of Tender Document
1
-
-
Rubella IgG , Please refer Annexure II of Tender Document
1
-
-
Rubella IgM , Please refer Annexure II of Tender Document
1
-
-
Toxo IgG , Please refer Annexure II of Tender Document
1
-
-
Toxo IgG Avidity , Please refer Annexure II of Tender Document
1
-
-
Toxo IgM , Please refer Annexure II of Tender Document
1
-
-
Chagas , Please refer Annexure II of Tender Document
1
-
-
EBV EBNA-1 , Please refer Annexure II of Tender Document
1
-
-
EBV VCA IgG , Please refer Annexure II of Tender Document
1
-
-
EBV VCA IgM , Please refer Annexure II of Tender Document
1
-
-
Syphilis TP , Please refer Annexure II of Tender Document
1
-
-
SARS-CoV-2 IgG , Please refer Annexure II of Tender Document
1
-
-
SARS-CoV-2 IgM , Please refer Annexure II of Tender Document
1
-
-
Active-B12 , Please refer Annexure II of Tender Document
1
-
-
Anti-CCP , Please refer Annexure II of Tender Document
1
-
-
B12 , Please refer Annexure II of Tender Document
1
-
-
C-Peptide , Please refer Annexure II of Tender Document
1
-
-
Cortisol , Please refer Annexure II of Tender Document
1
-
-
Ferritin , Please refer Annexure II of Tender Document
1
-
-
Folate , Please refer Annexure II of Tender Document
1
-
-
Insulin , Please refer Annexure II of Tender Document
1
-
-
Intact PTH , Please refer Annexure II of Tender Document
1
-
-
Vitamin D , Please refer Annexure II of Tender Document
1
-
-
Urine NGAL , Please refer Annexure II of Tender Document
1
-
-
Methotrexate , Please refer Annexure II of Tender Document
1
-
-
Anti-Tg , Please refer Annexure II of Tender Document
1
-
-
Anti-TPO , Please refer Annexure II of Tender Document
1
-
-
Free T3 , Please refer Annexure II of Tender Document
1
-
-
Free T4 , Please refer Annexure II of Tender Document
1
-
-
Total T3 , Please refer Annexure II of Tender Document
1
-
-
Total T4 , Please refer Annexure II of Tender Document
1
-
-
TSH , Please refer Annexure II of Tender Document
1
-
-
T-Uptake , Please refer Annexure II of Tender Document
1
-
-
Thyroglobulin -Tg , Please refer Annexure II of Tender Document
1
-
-
TR Ab , Please refer Annexure II of Tender Document
1
-
-
Cyclosporine , Please refer Annexure II of Tender Document
1
-
-
Sirolimus , Please refer Annexure II of Tender Document
1
-
-
Tacrolimus , Please refer Annexure II of Tender Document
1
-
-
HbA1c , Please refer Annexure II of Tender Document
1
-
-
Evaluation Notes How It Works ?
Potential Partner
Select Your Requirements